← Back
$LAB All transactions

STANDARD BIOTOOLS INC.

A

$ Value

$0

Shares

727,140

Price

$0

Filed

Apr 8

Insider

Name

Kim Hanjoon Alex

Title

Chief Financial Officer

CIK

0001919209

Roles

Officer

Transaction Details

Transaction Date

2026-03-20

Code

A

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

727,140

Footnotes

Represents restricted stock units ("RSUs") that vest over four years, with 1/16 of the RSUs vesting on May 20, 2026 and the remaining RSUs vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. Each RSU represents the right to receive one share of common stock upon vesting. | The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of restricted stock units ("RSUs") granted to the reporting person on April 4, 2022, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on April 6, 2022. | The Option becomes exercisable as to 1/16th of the underlying shares on May 20, 2026, with the remaining shares vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date. | Each RSU represents the contingent right to receive one share of the Issuer's common stock. | On April 4, 2022, the Reporting Person was granted 280,732 RSUs, vesting in four equal annual installments beginning on April 4, 2023.

Filing Info

Accession No.

0001193125-26-148613

Form Type

4

Issuer CIK

0001162194

Kim Hanjoon Alex's History

Date Ticker Type Value
2026-04-06 LAB M $0
2026-04-06 LAB F $19K
2026-04-06 LAB M $0
2026-03-20 LAB A $0
2026-03-20 LAB A $0
2025-08-20 LAB F $16K
2025-08-01 LAB A $0
2025-05-28 LAB F $3K
2025-05-23 LAB $1K
2025-05-22 LAB $1K

Other Insiders at LAB (90d)

Insider Bought Sold Last
Egholm Michael
President & CEO
2026-04-06
Mackay Sean
SVP & Chief Business Officer
2026-03-20
Kim Hanjoon Alex
Chief Financial Officer
2026-04-06